SANOFICONR Stock Overview
Operates as a fast-moving consumer healthcare company in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Community vs My Fair Value
Select a narrative for quick price alerts from the community, or create your own.
Sanofi Consumer Healthcare India Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹4,946.20 |
| 52 Week High | ₹5,375.00 |
| 52 Week Low | ₹4,211.55 |
| Beta | 0 |
| 1 Month Change | 5.31% |
| 3 Month Change | 2.55% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 0.87% |
Recent News & Updates
Recent updates
Shareholder Returns
| SANOFICONR | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -0.2% | 4.1% | 5.8% |
| 1Y | n/a | 14.4% | 3.7% |
Return vs Industry: Insufficient data to determine how SANOFICONR performed against the Indian Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how SANOFICONR performed against the Indian Market.
Price Volatility
| SANOFICONR volatility | |
|---|---|
| SANOFICONR Average Weekly Movement | 2.3% |
| Pharmaceuticals Industry Average Movement | 7.3% |
| Market Average Movement | 7.4% |
| 10% most volatile stocks in IN Market | 9.9% |
| 10% least volatile stocks in IN Market | 5.0% |
Stable Share Price: SANOFICONR has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: SANOFICONR's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2023 | 583 | Himanshu Bakshi | www.sanofi.com/en/Consumer-Healthcare/health-and-well-being |
Sanofi Consumer Healthcare India Limited operates as a fast-moving consumer healthcare company in India. It offers products in the allergy, physical wellness, and pain care segments under brands, such as Allegra, Combiflam, Avil, DePURA, Festal, and Novalgin NU through distributors, wholesalers, government institutions and hospitals, pharmacies, pharmacy chains, and e-commerce. The company was incorporated in 2023 and is based in Mumbai, India.
Sanofi Consumer Healthcare India Limited Fundamentals Summary
| SANOFICONR fundamental statistics | |
|---|---|
| Market cap | ₹113.89b |
| Earnings (TTM) | ₹1.81b |
| Revenue (TTM) | ₹7.25b |
62.9x
P/E Ratio15.7x
P/S RatioIs SANOFICONR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SANOFICONR income statement (TTM) | |
|---|---|
| Revenue | ₹7.25b |
| Cost of Revenue | ₹1.88b |
| Gross Profit | ₹5.37b |
| Other Expenses | ₹3.56b |
| Earnings | ₹1.81b |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 78.59 |
| Gross Margin | 74.09% |
| Net Profit Margin | 24.98% |
| Debt/Equity Ratio | 0% |
How did SANOFICONR perform over the long term?
See historical performance and comparisonDividends
1.1%
Current Dividend Yield70%
Payout RatioDoes SANOFICONR pay a reliable dividends?
See SANOFICONR dividend history and benchmarks| Sanofi Consumer Healthcare India dividend dates | |
|---|---|
| Ex Dividend Date | Apr 17 2025 |
| Dividend Pay Date | Jun 04 2025 |
| Days until Ex dividend | 6 days |
| Days until Dividend pay date | 42 days |
Does SANOFICONR pay a reliable dividends?
See SANOFICONR dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/22 13:48 |
| End of Day Share Price | 2025/04/22 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Sanofi Consumer Healthcare India Limited is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Rohit Bhat | Batlivala & Karani Securities India Pvt. Ltd. |
| Nitin Agarwal | DAM Capital Advisors |